Aurinia Pharmaceuticals
AUPH
#4681
Rank
A$3.19 B
Marketcap
A$23.84
Share price
1.54%
Change (1 day)
4.04%
Change (1 year)

EPS for Aurinia Pharmaceuticals (AUPH)

EPS in 2023 (TTM): A-$0.79

According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A$3.46. In 2022 the company made an earnings per share (EPS) of A-$1.10 an increase over its 2021 EPS that were of A-$2.04.

EPS history for Aurinia Pharmaceuticals from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$0.79-27.93%
2022A-$1.10-46.1%
2021A-$2.0463.95%
2020A-$1.25-33.85%
2019A-$1.8873.33%
2018A-$1.09-34.78%
2017A-$1.6774.24%
2016A-$0.9613.79%
2015A-$0.84-15.94%
2014A-$1.0061.51%
2013A-$0.62-83.03%
2012A-$3.65621.77%
2011A-$0.51-75.81%
2010A-$2.09-53.29%
2009A-$4.47-59.15%
2008A-$10.95-50.57%
2007A-$22.1516.07%
2006A-$19.08-28.86%
2005A-$26.8225.38%
2004A-$21.3951.08%
2003A-$14.164032.42%
2002A-$0.34
2000A-$12.73290.68%
1999A-$3.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regeneron Pharmaceuticals
REGN
A$60.70 1,653.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
A-$25.49-836.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
A-$2.97-185.73%๐Ÿ‡บ๐Ÿ‡ธ USA